Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 354 | 354 | 354 | 253 | 121 |
| Operating Expenses | 1,746 | 2,652 | 1,682 | 3,270 | 2,860 |
| Operating Income | -1,393 | -2,298 | -1,328 | -3,018 | -2,739 |
| Interest Expense | 7 | 6 | N/A | N/A | N/A |
| Other Income | 656 | -1,769 | -252 | 64 | -30 |
| Pre-tax Income | -743 | -4,073 | -1,580 | -2,954 | -2,769 |
| Net Income Continuous | -743 | -4,073 | -1,580 | -2,954 | -2,769 |
| Net Income | $-743 | $-4,073 | $-1,580 | $-2,954 | $-2,769 |
| EPS Basic Total Ops | -0.02 | -0.13 | -0.06 | -0.11 | -0.12 |
| EPS Basic Continuous Ops | -0.02 | -0.13 | -0.06 | -0.11 | -0.12 |
| EPS Diluted Total Ops | -0.02 | -0.13 | -0.06 | -0.11 | -0.12 |
| EPS Diluted Continuous Ops | -0.02 | -0.13 | -0.06 | -0.11 | -0.12 |
| EBITDA(a) | $-736 | $-4,067 | $-1,327 | $-3,016 | $-2,736 |